HIV-1/parasite co-infection and the emergence of new parasite strains

James O Lloyd-Smith1, Mary Poss, Bryan T Grenfell

  • 1Center for Infectious Disease Dynamics, Pennsylvania State University, 208 Mueller Lab, University Park, PA 16802, USA. jlloydsmith@psu.edu

Parasitology
|March 29, 2008
PubMed

Insights

Human immunodeficiency virus type 1 (HIV-1) infection can amplify parasitic infections, potentially facilitating the emergence of new parasite strains. Understanding these complex interactions is crucial for public health strategies.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Epidemiology

Background:

  • Co-circulation of Human Immunodeficiency Virus type 1 (HIV-1) and parasitic infections is common.
  • HIV-1 co-infection is known to amplify transmission for some parasites.
  • Population-level impacts of HIV-1 and parasite co-infection remain poorly understood.

Purpose of the Study:

  • To investigate how HIV-1 alters host immunity, influencing the emergence of novel parasite strains.
  • To review evidence on HIV-1 co-infection's impact on susceptibility and infectiousness for five parasitic diseases.
  • To model the population-level dynamics of parasite strains under varying HIV-1 prevalence.

Main Methods:

  • Literature review of clinical and epidemiological data for malaria, leishmaniasis, schistosomiasis, trypanosomiasis, and strongyloidiasis.
  • Analysis of how HIV-1 co-infection affects individual host susceptibility and infectiousness.
  • Development of a modeling framework to project population-level impacts.

Main Results:

  • HIV-1 can facilitate the invasion of new parasite strains in various scenarios.
  • Identified threshold levels of HIV-1 prevalence that enable the successful invasion of previously unsustainable parasite strains.
  • Demonstrated potential for HIV-1 to alter parasite evolution dynamics at the population level.

Conclusions:

  • HIV-1 co-infection presents a significant factor in the emergence and spread of parasitic strains.
  • Further research is needed to validate predicted effects due to a lack of definitive evidence.
  • Challenges in data interpretation and future study priorities were discussed.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...